Differential Transcriptome Profile of Peripheral White Cells to Identify Biomarkers Involved in Oxaliplatin Induced Neuropathy
Anticancer chemotherapy (CT) produces non-desirable effects on normal healthy cells and tissues. Oxaliplatin is widely used in the treatment of colorectal cancer and responsible for the development of sensory neuropathy in varying degrees, from complete tolerance to chronic neuropathic symptoms. We...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2014-06-01
|
| Series: | Journal of Personalized Medicine |
| Subjects: | |
| Online Access: | http://www.mdpi.com/2075-4426/4/2/282 |
| _version_ | 1797758955519213568 |
|---|---|
| author | Manuel Morales Julio Ávila Rebeca González-Fernández Laia Boronat María Luisa Soriano Pablo Martín-Vasallo |
| author_facet | Manuel Morales Julio Ávila Rebeca González-Fernández Laia Boronat María Luisa Soriano Pablo Martín-Vasallo |
| author_sort | Manuel Morales |
| collection | DOAJ |
| description | Anticancer chemotherapy (CT) produces non-desirable effects on normal healthy cells and tissues. Oxaliplatin is widely used in the treatment of colorectal cancer and responsible for the development of sensory neuropathy in varying degrees, from complete tolerance to chronic neuropathic symptoms. We studied the differential gene expression of peripheral leukocytes in patients receiving oxaliplatin-based chemotherapy to find genes and pathways involved in oxaliplatin-induced peripheral neuropathy. Circulating white cells were obtained prior and after three cycles of FOLFOX or CAPOX chemotherapy from two groups of patients: with or without neuropathy. RNA was purified, and transcriptomes were analyzed. Differential transcriptomics revealed a total of 502 genes, which were significantly up- or down-regulated as a result of chemotherapy treatment. Nine of those genes were expressed in only one of two situations: CSHL1, GH1, KCMF1, IL36G and EFCAB8 turned off after CT, and CSRP2, IQGAP1, GNRH2, SMIM1 and C5orf17 turned on after CT. These genes are likely to be associated with the onset of oxaliplatin-induced peripheral neuropathy. The quantification of their expression in peripheral white cells may help to predict non-desirable side effects and, consequently, allow a better, more personalized chemotherapy. |
| first_indexed | 2024-03-12T18:37:27Z |
| format | Article |
| id | doaj.art-fb2ab1a112e549c18d7692c7278de9bb |
| institution | Directory Open Access Journal |
| issn | 2075-4426 |
| language | English |
| last_indexed | 2024-03-12T18:37:27Z |
| publishDate | 2014-06-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Journal of Personalized Medicine |
| spelling | doaj.art-fb2ab1a112e549c18d7692c7278de9bb2023-08-02T07:57:17ZengMDPI AGJournal of Personalized Medicine2075-44262014-06-014228229610.3390/jpm4020282jpm4020282Differential Transcriptome Profile of Peripheral White Cells to Identify Biomarkers Involved in Oxaliplatin Induced NeuropathyManuel Morales0Julio Ávila1Rebeca González-Fernández2Laia Boronat3María Luisa Soriano4Pablo Martín-Vasallo5Service of Oncology, Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, 38010 Tenerife, SpainDevelopmental Biology Laboratory, Department of Biochemistry and Molecular Biology, University of La Laguna, Av. Astrofísico Sánchez s/n, 38206 La Laguna, SpainDevelopmental Biology Laboratory, Department of Biochemistry and Molecular Biology, University of La Laguna, Av. Astrofísico Sánchez s/n, 38206 La Laguna, SpainService of Oncology, Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, 38010 Tenerife, SpainService of Oncology, Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, 38010 Tenerife, SpainDevelopmental Biology Laboratory, Department of Biochemistry and Molecular Biology, University of La Laguna, Av. Astrofísico Sánchez s/n, 38206 La Laguna, SpainAnticancer chemotherapy (CT) produces non-desirable effects on normal healthy cells and tissues. Oxaliplatin is widely used in the treatment of colorectal cancer and responsible for the development of sensory neuropathy in varying degrees, from complete tolerance to chronic neuropathic symptoms. We studied the differential gene expression of peripheral leukocytes in patients receiving oxaliplatin-based chemotherapy to find genes and pathways involved in oxaliplatin-induced peripheral neuropathy. Circulating white cells were obtained prior and after three cycles of FOLFOX or CAPOX chemotherapy from two groups of patients: with or without neuropathy. RNA was purified, and transcriptomes were analyzed. Differential transcriptomics revealed a total of 502 genes, which were significantly up- or down-regulated as a result of chemotherapy treatment. Nine of those genes were expressed in only one of two situations: CSHL1, GH1, KCMF1, IL36G and EFCAB8 turned off after CT, and CSRP2, IQGAP1, GNRH2, SMIM1 and C5orf17 turned on after CT. These genes are likely to be associated with the onset of oxaliplatin-induced peripheral neuropathy. The quantification of their expression in peripheral white cells may help to predict non-desirable side effects and, consequently, allow a better, more personalized chemotherapy.http://www.mdpi.com/2075-4426/4/2/282transcriptome profilechemotherapyoxaliplatinneuropathyFOLFOXCAPOXcolon-adenocarcinoma |
| spellingShingle | Manuel Morales Julio Ávila Rebeca González-Fernández Laia Boronat María Luisa Soriano Pablo Martín-Vasallo Differential Transcriptome Profile of Peripheral White Cells to Identify Biomarkers Involved in Oxaliplatin Induced Neuropathy Journal of Personalized Medicine transcriptome profile chemotherapy oxaliplatin neuropathy FOLFOX CAPOX colon-adenocarcinoma |
| title | Differential Transcriptome Profile of Peripheral White Cells to Identify Biomarkers Involved in Oxaliplatin Induced Neuropathy |
| title_full | Differential Transcriptome Profile of Peripheral White Cells to Identify Biomarkers Involved in Oxaliplatin Induced Neuropathy |
| title_fullStr | Differential Transcriptome Profile of Peripheral White Cells to Identify Biomarkers Involved in Oxaliplatin Induced Neuropathy |
| title_full_unstemmed | Differential Transcriptome Profile of Peripheral White Cells to Identify Biomarkers Involved in Oxaliplatin Induced Neuropathy |
| title_short | Differential Transcriptome Profile of Peripheral White Cells to Identify Biomarkers Involved in Oxaliplatin Induced Neuropathy |
| title_sort | differential transcriptome profile of peripheral white cells to identify biomarkers involved in oxaliplatin induced neuropathy |
| topic | transcriptome profile chemotherapy oxaliplatin neuropathy FOLFOX CAPOX colon-adenocarcinoma |
| url | http://www.mdpi.com/2075-4426/4/2/282 |
| work_keys_str_mv | AT manuelmorales differentialtranscriptomeprofileofperipheralwhitecellstoidentifybiomarkersinvolvedinoxaliplatininducedneuropathy AT julioavila differentialtranscriptomeprofileofperipheralwhitecellstoidentifybiomarkersinvolvedinoxaliplatininducedneuropathy AT rebecagonzalezfernandez differentialtranscriptomeprofileofperipheralwhitecellstoidentifybiomarkersinvolvedinoxaliplatininducedneuropathy AT laiaboronat differentialtranscriptomeprofileofperipheralwhitecellstoidentifybiomarkersinvolvedinoxaliplatininducedneuropathy AT marialuisasoriano differentialtranscriptomeprofileofperipheralwhitecellstoidentifybiomarkersinvolvedinoxaliplatininducedneuropathy AT pablomartinvasallo differentialtranscriptomeprofileofperipheralwhitecellstoidentifybiomarkersinvolvedinoxaliplatininducedneuropathy |